sellModerate cluster of 3
Bissell John sold $41k of ORGN
Co-CEO and Director at Origin Materials, Inc.. 36,000 shares at an average of $1.14, traded Dec 13, 2024, filed Dec 17, 2024.
Warning score
46Value
$41k
36,000 shares
Holdings after
1,581,230
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-029580, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 13, 2024 | SOpen-market sale Common Stock | -36,000 | $1.14 | $41k | 1,581,230 | Dec 17, 2024 |
Related signals
Other insiders at Origin Materials, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 47Moderate | sell 3 | ORGN Origin Materials, Inc. | Bissell John CEO and Director | $55k | 55,000 | |
| 15Weak | sell 310b5-1 | ORGN Origin Materials, Inc. | Lee Joshua C. General Counsel | $26k | 25,000 | |
| 22Weak | sell 310b5-1 | ORGN Origin Materials, Inc. | Plavan Matthew T CFO and COO | $25k | 24,500 | |
| 17Weak | sell 310b5-1 | ORGN Origin Materials, Inc. | Lee Joshua C. General Counsel | $51k | 47,625 | |
| 34Weak | buy10b5-1 | ORGN Origin Materials, Inc. | Riley Richard J. CO-CEO AND DIRECTOR | $300k | 300,000 | |
| 40Moderate | sell 3 | ORGN Origin Materials, Inc. | Bissell John Co-CEO and Director | $8,260 | 6,598 | |
| 30Weak | sell 3 | ORGN Origin Materials, Inc. | Lee Joshua C. General Counsel | $11k | 8,784 | |
| 48Moderate | sell 3 | ORGN Origin Materials, Inc. | Plavan Matthew T Chief Financial Officer | $158k | 120,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.